375 related articles for article (PubMed ID: 22568716)
1. Interactions between Streptococcus pneumoniae and influenza virus: a mutually beneficial relationship?
Short KR; Habets MN; Hermans PW; Diavatopoulos DA
Future Microbiol; 2012 May; 7(5):609-24. PubMed ID: 22568716
[TBL] [Abstract][Full Text] [Related]
2. Lethal coinfection of influenza virus and Streptococcus pneumoniae lowers antibody response to influenza virus in lung and reduces numbers of germinal center B cells, T follicular helper cells, and plasma cells in mediastinal lymph Node.
Wu Y; Tu W; Lam KT; Chow KH; Ho PL; Guan Y; Peiris JS; Lau YL
J Virol; 2015 Feb; 89(4):2013-23. PubMed ID: 25428873
[TBL] [Abstract][Full Text] [Related]
3. The dangerous synergism between influenza and Streptococcus pneumoniae and innovative perspectives of vaccine prevention.
Alicino C; Iudici R; Alberti M; Durando P
J Prev Med Hyg; 2011 Sep; 52(3):102-6. PubMed ID: 22010535
[TBL] [Abstract][Full Text] [Related]
4. High nasopharyngeal pneumococcal density, increased by viral coinfection, is associated with invasive pneumococcal pneumonia.
Wolter N; Tempia S; Cohen C; Madhi SA; Venter M; Moyes J; Walaza S; Malope-Kgokong B; Groome M; du Plessis M; Magomani V; Pretorius M; Hellferscee O; Dawood H; Kahn K; Variava E; Klugman KP; von Gottberg A
J Infect Dis; 2014 Nov; 210(10):1649-57. PubMed ID: 24907383
[TBL] [Abstract][Full Text] [Related]
5. Increase of apoptosis in a murine model for severe pneumococcal pneumonia during influenza A virus infection.
Kosai K; Seki M; Tanaka A; Morinaga Y; Imamura Y; Izumikawa K; Kakeya H; Yamamoto Y; Yanagihara K; Tomono K; Kohno S
Jpn J Infect Dis; 2011; 64(6):451-7. PubMed ID: 22116322
[TBL] [Abstract][Full Text] [Related]
6. Influenza promotes pneumococcal growth during coinfection by providing host sialylated substrates as a nutrient source.
Siegel SJ; Roche AM; Weiser JN
Cell Host Microbe; 2014 Jul; 16(1):55-67. PubMed ID: 25011108
[TBL] [Abstract][Full Text] [Related]
7. GP96 Drives Exacerbation of Secondary Bacterial Pneumonia following Influenza A Virus Infection.
Sumitomo T; Nakata M; Nagase S; Takahara Y; Honda-Ogawa M; Mori Y; Akamatsu Y; Yamaguchi M; Okamoto S; Kawabata S
mBio; 2021 Jun; 12(3):e0326920. PubMed ID: 34061598
[TBL] [Abstract][Full Text] [Related]
8. Modeling Influenza Virus Infection: A Roadmap for Influenza Research.
Boianelli A; Nguyen VK; Ebensen T; Schulze K; Wilk E; Sharma N; Stegemann-Koniszewski S; Bruder D; Toapanta FR; Guzmán CA; Meyer-Hermann M; Hernandez-Vargas EA
Viruses; 2015 Oct; 7(10):5274-304. PubMed ID: 26473911
[TBL] [Abstract][Full Text] [Related]
9. Memory Th17 cell-mediated protection against lethal secondary pneumococcal pneumonia following influenza infection.
Li Y; Yang Y; Chen D; Wang Y; Zhang X; Li W; Chen S; Wong SM; Shen M; Akerley BJ; Shen H
mBio; 2023 Aug; 14(4):e0051923. PubMed ID: 37222516
[No Abstract] [Full Text] [Related]
10. Synergism and Antagonism of Bacterial-Viral Coinfection in the Upper Respiratory Tract.
Manna S; McAuley J; Jacobson J; Nguyen CD; Ullah MA; Sebina I; Williamson V; Mulholland EK; Wijburg O; Phipps S; Satzke C
mSphere; 2022 Feb; 7(1):e0098421. PubMed ID: 35044807
[TBL] [Abstract][Full Text] [Related]
11. Insights into the interaction between influenza virus and pneumococcus.
McCullers JA
Clin Microbiol Rev; 2006 Jul; 19(3):571-82. PubMed ID: 16847087
[TBL] [Abstract][Full Text] [Related]
12. Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor.
McCullers JA; Rehg JE
J Infect Dis; 2002 Aug; 186(3):341-50. PubMed ID: 12134230
[TBL] [Abstract][Full Text] [Related]
13. Risk modelling the mortality impact of antimicrobial resistance in secondary pneumococcal pneumonia infections during the 2009 influenza pandemic.
Barnes CE; MacIntyre CR
Int J Infect Dis; 2019 Aug; 85():1-6. PubMed ID: 31096052
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effects of garenoxacin in murine experimental secondary pneumonia by Streptococcus pneumoniae after influenza virus infection.
Fukuda Y; Furuya Y; Nozaki Y; Takahata M; Nomura N; Mitsuyama J
Diagn Microbiol Infect Dis; 2014 Feb; 78(2):168-71. PubMed ID: 24321356
[TBL] [Abstract][Full Text] [Related]
15. Influenza virus-mediated suppression of bronchial Chitinase-3-like 1 secretion promotes secondary pneumococcal infection.
Karwelat D; Schmeck B; Ringel M; Benedikter BJ; Hübner K; Beinborn I; Maisner A; Schulte LN; Vollmeister E
FASEB J; 2020 Dec; 34(12):16432-16448. PubMed ID: 33095949
[TBL] [Abstract][Full Text] [Related]
16.
Bradshaw JL; Caballero AR; Bierdeman MA; Adams KV; Pipkins HR; Tang A; O'Callaghan RJ; McDaniel LS
mSphere; 2018; 3(3):. PubMed ID: 29720526
[TBL] [Abstract][Full Text] [Related]
17. Influenza and community-acquired pneumonia interactions: the impact of order and time of infection on population patterns.
Davis BM; Aiello AE; Dawid S; Rohani P; Shrestha S; Foxman B
Am J Epidemiol; 2012 Mar; 175(5):363-7. PubMed ID: 22247048
[TBL] [Abstract][Full Text] [Related]
18. Influenza virus amplifies interaction of polymeric immunoglobulin receptor with pneumococcal surface protein A, which mediates invasion by pneumococcus.
Eisenhut M
J Infect Dis; 2010 Apr; 201(8):1272-3; author reply 1273. PubMed ID: 20225960
[No Abstract] [Full Text] [Related]
19. Toll-Like Receptor 3/TRIF-Dependent IL-12p70 Secretion Mediated by Streptococcus pneumoniae RNA and Its Priming by Influenza A Virus Coinfection in Human Dendritic Cells.
Spelmink L; Sender V; Hentrich K; Kuri T; Plant L; Henriques-Normark B
mBio; 2016 Mar; 7(2):e00168-16. PubMed ID: 26956584
[TBL] [Abstract][Full Text] [Related]
20. Inflammation as a Modulator of Host Susceptibility to Pulmonary Influenza, Pneumococcal, and Co-Infections.
Aguilera ER; Lenz LL
Front Immunol; 2020; 11():105. PubMed ID: 32117259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
